Research on the use of Musa paradisiaca L. in the treatment of individuals with respiratory diseases in the city of Curitiba-PR
DOI:
https://doi.org/10.70151/vhbhnd07Keywords:
asthma, banana, bronchitis, inflorescences, Musa paradisiaca L.Abstract
Allergic asthma is a chronic disease characterized by inflammation of the airways. This disease is considered a public health problem and is estimated to affect 300 million people worldwide. In Brazil, a large part of the population affected by asthma has no access to medicines or does not respond to treatment, resulting in a considerable number of patients attending the emergency room. In this context, alternative treatments with medicinal plants become relevant as they are easily accessible and inexpensive. Among these plants, it stands out the species Musa paradisiaca L., popularly known as banana, from which the inflorescence is used to treat respiratory diseases. In view of the popular use, the present study aimed to investigate the use of this plant, verifying from the part used, the way of preparation, the form of use, the time of consumption, the improvement of the symptoms, the possible side effects and concomitant use of other medicines. The cross-sectional descriptive study was carried out with 21 participants and the data collection was done through a printed questionnaire. Among the participants, 81% described that they prepared the syrup by mixing the inflorescences with honey. Regarding the therapeutic purpose, most reported use for asthma (52.4%) and bronchitis (28.6%). In addition, all patients reported improvement in symptoms after treatment. These results indicate a possible anti-inflammatory action of the banana inflorescence. However, further studies on the chemical composition and pharmacological action should be performed in order to guarantee patient safety and treatment efficacy.
Downloads
References
Acharya J, Karak S.; De B (2016) Metabolite Profile and Bioactivity of Musa X Paradisiaca L. Flower Extracts. J. Food Biochem. 40(6): 724-730.
https://doi.org/10.1111/jfbc.12263
Adelroth E, Hargreave FE, Ramsdale EH (1986) Do physicians need objective measurements to diagnose asthma? Am. Rev. Respir. Dis. 134(4): 704-7. https://doi.org/10.1164/arrd.1986.134.4.704
Barnes PJ (2008) Immunology of asthma and chronic obstructive pulmonary disease. Nat. Rev. Immunol. 8(3): 183-92. DOI: 10.1038/nri2254
BRASIL. Ministério da Saúde. Conselho Nacional de Saúde. Resolução n. 466, de 12 de dezembro de 2012. Disponível em: <http://bvsms.saude.gov.br/bvs/saudelegis/cns/ 2013/res0466_12_12_2012.html >. Acesso em: 01 jun. 2017.
BRASIL. Ministério da Saúde. DATASUS. Disponível em: <http://tabnet.datasus.gov.br/ cgi/tabcgi.exe?sih/cnv/niuf.def>. Acesso em: 01 mai. 2017.
Caetano NLB, Ferreira TF, Reis MRO, Neo GGA, Carvalho AA (2015) Plantas medicinais utilizadas pela população do município de Lagarto-SE, Brasil ênfase em pacientes oncológicos. Rev. Bras. Plantas Med. 17: 748-756.
https://doi.org/10.1590/1983-084X/14_056
GLOBAL INITIATIVE FOR ASTHMA. Global Strategy for Asthma Management and Prevention. Disponível em: <http://ginasthma.org/2017-gina-report-global-strategy-for-asthma-management-and-prevention/>. Acesso em: 01 jun. 2017.
Grassin-Delyle S, Girodet PO (2012) Asthma exacerbations: pharmacological prevention. Rev. Malad. Respir. 29(2): 232-244.
https://doi.org/10.1016/j.rmr.2011.05.018
Holgate ST (2000) Inflammatory and structural changes in the airways of patients with asthma. Respirat. Med. 94(Suppl D): S3-6,
https://doi.org/10.1016/s0954-6111(00)90116-1
Holgate ST, Polosa R (2008) Treatment strategies for allergy and asthma. Nat. Rev. Immunol. 8(3): 218-230.
https://doi.org/10.1038/nri2262
IBGE. Instituto Brasileiro de Geografia e Estatística. Cidades. Disponível em: <http://cidades.ibge.gov.br/xtras/perfil.php?lang=&codmun=410690&search=parana|curitiba>. Acesso em: 04 jun. 2017.
Jones CC, Becer EA, Catrambone AD, Martin MA (2013) A guideline-based approach to asthma management. Nurs. Clin. North Am.48(1): 35-45.
https://doi.org/10.1016/j.cnur.2012.12.007
Li XM, Brown L (2009) Efficacy and mechanisms of action of traditional Chinese medicines for treating asthma and allergy. J. Allergy Clin. Immunol. 123(2):. 297-306; quiz 307-8.
https://doi.org/10.1016/j.jaci.2008.12.026
Mahmood A, Ngah N, Omar MN (2011) Phytochemicals Constituent and Antioxidant Activities in Musa x Paradisiaca Flower. Eur. J. Sci. Res. 66(2): 311-318.
Nisha P, Mini S (2013) Flavanoid rich ethyl acetate fraction of Musa paradisiaca inflorescence down-regulates the streptozotocin induced oxidative stress, hyperglycaemia and mRNA levels of selected inflammatory genes in rats. J. Funct. Foods. 5(4): 1838-1847.
https://dx.doi.org/10.1016/j.jff.2013.09.003
Olaguibel JM, Quirce S, Juliá B, Fernández C, Fortura AM, Molina J, Plaza V, Magic Study Group (2012) Measurement of asthma control according to global initiative for asthma guidelines: a comparison with the asthma control questionnaire. Respir. Res. 13(1): 50
https://doi.org/10.1186/1465-9921-13-50
Sociedade Brasileira de Pneumologia e Tisiologia (2012). Diretrizes da Sociedade Brasileira de Pneumologia e Tisiologia para o Manejo da Asma. J Bras Pneumol 38(1):S1-S46.
Sens SL Alternativas para a auto-sustentabilidade dos xokleng da terra indígena Ibirama. 2002. 365p. Dissertação (Mestrado) - Programa de Pós-Graduação em Engenharia de Produção, Universidade Federal de Santa Catarina, Florianópolis.
Stoloff SW (2008) Asthma management and prevention: Current perspectives. Clin. Cornerstone 8(4): 26-43. https://doi.org/10.1016/s1098-3597(08)80011-7
Tanaka T, Takahashi R (2013) Flavonoids and Asthma. Nutrients 5(6): 2128. https://doi.org/10.3390/nu5062128
Toshio T (2014) Flavonoids for Allergic Diseases: Present Evidence and Future Perspective. Curr. Pharm. Des. 20(6): 879-885. DOI: 10.2174/13816128113199990060
Veiga-Junior VF, Pinto AC, Maciel MAM (2005). Plantas medicinais: cura segura? Quím. Nova 28: 519-528. http://dx.doi.org/10.21577/0100-4042.20170710
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.